Skip to content

Fighting to Preserve the Benefits of the 340B Program

Facebook page opens in new windowX page opens in new windowLinkedin page opens in new windowMail page opens in new window
RWC-340B
Ryan White Clinics for 340B Access
RWC-340B
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles
Search:
  • Members
    • RWC-340B Members
    • Become a Member
  • Benefactors
    • Meet Our Benefactors
    • Benefactor Application
  • Expert Advice
    • Outline of Technical Assistance
    • Peer-to-Peer Mentoring
  • Advocacy
    • Get The Facts
    • TAKE ACTION
    • Congressional Advocacy
    • Regulatory Advocacy
    • State Advocacy
    • Litigation
  • Issues
    • Contract Pharmacy
    • Discriminatory Reimbursement Toolkit
    • Carve-out Toolkit
    • PrEP Toolkit
    • COVID-19 Toolkit
    • RWC-340B Key Research
  • Events
    • Conferences
  • News
  • About Us
    • RWC-340B Principles

Recap of Second 340B ESP™ Basic User Training Webinar

Drug Pricing, News, RWC-340BBy adminAugust 28, 2020

On August 26, Second Sight Solutions, the owner of the 340B ESP™ platform, hosted the second in a series of webinars on 340B ESP™.  The webinar, entitled Data Security, Privacy,…

RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers

Drug Pricing, News, RWC-340BBy adminAugust 27, 2020

Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca.  In the statement, RWC-340B calls…

Manufacturers to Provide “340B Rebates” Through New Kalderos Software Platform

Drug Pricing, News, RWC-340BBy adminAugust 27, 2020

This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program operates – shifting a manufacturer’s…

Novartis To Collect Contract Pharmacy Claims Data Through 340B ESP, TPAs and Specialty Pharmacies Express Concern Over Data Submitted

Drug Pricing, HRSA, NewsBy adminAugust 20, 2020

Earlier this week a third drug manufacturer, Novartis Pharmaceuticals, sent letters to 340B covered entities with contract pharmacy arrangements stating that beginning October 1, 2020, covered entities will be required…

Astra-Zeneca Announces It Will No Longer Offer 340B Discounts at Most Contract Pharmacies

Drug Pricing, HRSA, NewsBy adminAugust 17, 2020

Today, Astra-Zeneca joined other manufacturers in announcing that it would no longer honor all contract pharmacy arrangements. Astra-Zeneca sent letters to 340B covered entities informing them that, effective October 1,…

Reps. Matsui and Stewart Introduce Legislation to Protect 340B Hospitals During COVID-19 Pandemic

Congress, Drug Pricing, News, RWC-340BBy adminAugust 6, 2020

On July 29, Reps. Doris Matsui (D-CA) and Chris Stewart (R-UT) introduced a bill that would protect 340B hospitals from losing their covered entity status and allow flexibility in how…

                                                                            © 2021 Ryan White Clinics for 340B Access. RWC-340B is a 501(c)(4) non-profit corporation.
Go to Top
Translate »